PARIS, May 12 (Reuters) - U.S. pharmaceutical and healthcare giant Pfizer announced on Sunday a 500 million-euro ($538 million) investment in France for research and development, ahead of the start of this year's annual 'Choose France' business summit. ($1 = 0.9286 euros) (Reporting by Sudip Kar-Gupta and Elizabeth Pineau; Editing by Hugh Lawson)
Market Closed -
Other stock markets
|
After market 07:50:44 pm | |||
28.66 USD | +1.63% | 28.56 | -0.37% |
May. 31 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
May. 31 | Sector Update: Health Care Stocks Advance Friday Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.45% | 162B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer announces 500 million euros investment in France